Photo: Getty Images

The $40 billion in new health care deals announced Thursday shows there’s more to M&A than tax breaks.

Abbott Laboratories agreed to buy St. Jude Medical Inc., a maker of heart devices, for $25 billion, the company’s biggest ever acquisition. AbbVie Inc. agreed to buy closely held cancer drugmaker Stemcentrx for $5.8 billion. France’s Sanofi, in a bid to build up its pipeline of new treatments, made a $9.3 billion unsolicited offer for Medivation Inc.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?


© 2023 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.